Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Premature discontinuation during the UPLIFT study.

Decramer M, Molenberghs G, Liu D, Celli B, Kesten S, Lystig T, Tashkin DP; UPLIFT investigators.

Respir Med. 2011 Oct;105(10):1523-30. doi: 10.1016/j.rmed.2011.04.002. Epub 2011 May 6.

2.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators.

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

3.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators.

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk